Characterization of suppressor cells in mice bearing syngeneic mastocytoma
- PMID: 65423
Characterization of suppressor cells in mice bearing syngeneic mastocytoma
Abstract
Suppressor cells from syngeneic P815 mastocytoma-bearing DBA/2 mice that inhibit in vitro generation of specific anti-tumor cytotoxicity were characterized. Suppressive activity was almost completely eliminated by treating suppressive spleen cells with anti-theta serum and complement. Treatment with anti-mouse lg serum and complement or with carbonyl iron did not affect their suppressive activity. When suppressive thymocytes from P815 tumor-bearing DBA/2 mice were tested for their capacity to inhibit the generation of cytotoxicity against L1210 cells, a leukemia line in DBa/2 mice, they did not affect the activity, indicating that the supressor cells in the thymocytes of P815 tumor-bearing mice are specific to the tumor. When Ficoll-Hypaque density cell separation was carried out with cytotoxic spleen cells and suppressive spleen cells from 815 tumor-bearing mice, the dense fraction was enriched for kiler cells whereas the suppressive activitty was mainly recovered in the light fraction. Therefore, killer cells and suppressor cells in P815 tumor-bearing mice are thought to be distinct populations.
Similar articles
-
In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.J Immunol. 1976 Feb;116(2):288-93. J Immunol. 1976. PMID: 814160
-
Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.J Immunol. 1976 May;116(5):1342-6. J Immunol. 1976. PMID: 1270799
-
Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.J Immunol. 1979 Mar;122(3):766-71. J Immunol. 1979. PMID: 109502
-
Characterization of a soluble factor that specifically suppresses the in vitro generation of cells cytotoxic for syngeneic tumor cells in mice.J Immunol. 1978 Apr;120(4):1218-24. J Immunol. 1978. PMID: 417138
-
Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.Am J Pathol. 1976 Dec;85(3):661-74. Am J Pathol. 1976. PMID: 826167 Free PMC article.
Cited by
-
Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.J Exp Med. 1983 Mar 1;157(3):1040-52. doi: 10.1084/jem.157.3.1040. J Exp Med. 1983. PMID: 6187879 Free PMC article.
-
Fc-receptor-bearing cells in spleen of mice injected with cell-free Ehrlich ascites fluid (EAF).Blut. 1980 Oct;41(4):269-76. doi: 10.1007/BF01020527. Blut. 1980. PMID: 6448644
-
Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.Clin Exp Immunol. 1979 Jan;35(1):53-61. Clin Exp Immunol. 1979. PMID: 154982 Free PMC article.
-
Cancer immunotherapy.Can Med Assoc J. 1979 Feb 3;120(3):255, 258. Can Med Assoc J. 1979. PMID: 311678 Free PMC article. No abstract available.
-
Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor.Cancer Immunol Immunother. 1982;13(2):134-9. doi: 10.1007/BF00205314. Cancer Immunol Immunother. 1982. PMID: 6819080 Free PMC article.